Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BOWEL MANAGEMENT DEVICES (EFFECTIVE 07/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOVASCULAR REPAIR OF ILIAC ARTERY BIFURCATION - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ITCA 650 (EXENATIDE) - RETIRED AS OF 06/09/2022 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR FAMILIAL CUTANEOUS MALIGNANT MELANOMA (CDKN2A) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BONE MARROW TRANSPLANTATION FOR MALIGNANT ASTROCYTOMAS AND GLIOMAS, AUTOLOGOUS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POWERED BONE MARROW ASPIRATION AND BIOPSY SYSTEMS (ONCONTROL) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PRENATAL (FETAL) SURGERY FOR DIAGNOSED MALFORMATIONS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROSTATE CANCER EARLY DETECTION: BIOMARKERS PRIOR TO BIOPSY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR GERM-CELL TUMORS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR PHARMACOGENETIC PAIN MANAGEMENT - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TONIC MOTOR ACTIVATION (TOMAC) FOR RESTLESS LEGS SYNDROME | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SURGICAL TREATMENT FOR MALE GYNECOMASTIA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MEDICAL POLICY – Avlayah (tividenofusp alfa-eknm) 12-25 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OBSTRUCTIVE SLEEP APNEA - NON-SURGICAL TREATMENT | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INHALED NITRIC OXIDE (INO) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CONTINUOUS INTRAOCULAR PRESSURE MONITORING- MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIR AMBULANCE SERVICES FOR NON-EMERGENT TRANSPORTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CHEMICAL PEELS (EFFECTIVE 09/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMMUNE CELL FUNCTION ASSAY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE FLUORESCENCE IMAGING SYSTEMS (SPY IMAGING) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSITRON EMISSION TOMOGRAPHY (PET) FOR ONCOLOGIC CONDITIONS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTERSPINOUS / INTERLAMINAR STABILIZATION / DISTRACTION DEVICES (SPACERS) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SKIN AND TISSUE SUBSTITUTES (11/01/2025) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NERVE GRAFT WITH RADICAL PROSTATECTOMY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | EVALUATION OF BIOMARKERS FOR ALZHEIMER’S DISEASE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | URINARY BIOMARKERS FOR BLADDER CANCER - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR MYOTONIC DYSTROPHY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROACT ADJUSTABLE CONTINENCE THERAPY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LOW-DOSE RADIOFREQUENCY FOR NASAL VALVE REMODELING | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSPLANT-LUNG/DOUBLE LUNG AND LIVER (COMBINED) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CALCITONIN GENE RELATED PEPTIDE (CGRP) ANTAGONISTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR PTEN HAMARTOMA TUMOR SYNDROME | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NAB-PACLITAXEL; PACLITAXEL PROTEIN-BOUND PARTICLES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SYNAGIS ( PALIVIZUMAB) - RETIRED - 2/12/2026 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SURGERY FOR GROIN PAIN IN ATHLETES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOPERATIVE FLUORESCENCE IMAGING SYSTEMS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AUTOMATED POINT-OF-CARE NERVE CONDUCTION TESTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVENOUS BISPHOSPHONATES (retired 04/08/2021) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SUPRACHOROIDAL DELIVERY OF PHARMACOLOGIC AGENTS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR DUCHENNE AND BECKER MUSCULAR DYSTROPHY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR RETT SYNDROME - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRANSMYOCARDIAL (PERVENTRICULAR) CLOSURE OF VENTRICULAR SEPTAL DEFECTS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ENDOVASCULAR THERAPIES FOR EXTRACRANIAL VERTEBRAL ARTERY DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR RETINAL DYSTROPHIES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MICROCURRENT ELECTRICAL NEUROSTIMULATION (MENS) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | RESPONSIVE NEUROSTIMULATION FOR THE TREATMENT OF REFRACTORY FOCAL EPILEPSY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETOENCEPHALOGRAPHY/MAGNETIC SOURCE IMAGING - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MYELOPEROXIDASE (MPO) IMMUNOASSAY FOR CARDIAC DISEASE RISK | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CT (COMPUTED TOMOGRAPHY) PERFUSION IMAGING OF THE BRAIN | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONCONTACT ULTRASOUND TREATMENT FOR WOUNDS - MEDICARE ADVANTAGE | New policy |